Search Results

You are looking at 1 - 1 of 1 items for :

  • "anti-SLAMF7" x
  • All content x
Clear All
Authors: Apor Hardi, András Kozma, Andrea Ceglédi, Ágnes Tomán, András Bors, Hajnalka Andrikovics, and Gábor Mikala

Pazina T, James AM, MacFarlane AW, Bezman NA, Henning KA, et al. The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and independent mechanisms. Oncoimmunology 2017; 6

Restricted access